Wisdomtree Japan Equity Ucits Etf J (0Y82) Noticias

Yea it will show previous posts but that includes every board I posted on and in that order. No way to find them that fast. By the way, all the boards I posted on? Most I made good money on and did not bry like a citch 11,000 + times and stalk the posters. You reloaded flipping hoping to attack and

Cardano Users Can Now Earn Up TO 21% APY From Their Wallets
https://cryptonewsland.com/earn-up-to-21-apy/

Why do you like me so much? Want my phone number? I am not single.

By now you are clueless how this OTC stock stuff works. By now your posts are laughable and completely clowns

You got stuck reloading and want to blame me? Learn to trade.

Heading to $$$$$

I have11,414 pieces of evidence that will show you slanderous statements.

I believe you are describing conditional approval, not confirmatory.

Attila, Agree. It is clear that the DCVax-L Phase 3 results are strong and points toward full approval for GBM, as the MAA application was submitted for.

If there is going to be any conditional approval, my guess is it would be an expanded label to treat Grade 3 brain tumors. Not sayi

NICE@NICEComms : "Our mission is to get the best treatments to people fast. The latest NHS Innovation Scorecard shows 73.1% of NICE-recommended treatments were prescribed more in 2024 than the year before"⤵️

https://x.com/peter_brit/status/1916001005814133108

But you leave out the part that I posted those things to make you. Yes you. Happy. You are twisting words and leaving out key parts of sentences. Why attack me with false and misleading posts like this?

Exactly. I am being stalked.

Ah very good - some thinking alignment happening. Btw. did you just indirectly describe a "Precision Medicine" trial confirming label from subgroup analysis - you can have a cookie!

Heading back to 0001 soon!  
SCAM run by SCUM! 😆🤣😂ZERO assets!         
ZERO revenues!         
ZERO financials!         
ZERO credibility CEO!         
ZERO share price coming!       
Delisting soon 👏

You are forgetting the Anavex factor in between tre CHMP process days plus the handover to EMA for a final decision. Feb'ish maybe!

SPY ELLIOT WAVE

i believe this gentleman has been doing Elliot wave analysis for 50 years

no one is ever 100% accurate but he has a pretty good track record and gives great informatio

[

https://youtu.be/3eoqZL57rU8?si=8fmkzEut8IJluFnl

Bashers teaming up posting gibberish relentlessly and providing awesome hilarious entertainment! One of them just created a brand new bashing account lekavej571 few hours ago and of course other famous resident bashers GetPoorFast and Lime. Keep it coming. Looks like your bottoms are literally off w

The Warrants were issued by James Lockhart, as opposed to, to James Lockhart. They've bean received by da Gooberment. Just Sayin!

Fannie Mae - Keep The Fight Alive
Fight, Fight, Fight
Fight For What Is Right
Fight to Right the Wrongs Done to Shareholders
Justice - Freedom - Liberty - Honesty - America

Am trying to draw attention to the current  DOJ's Antitrust Policy Priorities shown in the link, but cant get the dadgum thing to work.

One thing that sincerely conflicts in me about NRSN is not only that absence of a signed partnership, but on the flip side the conspicuous absence of some sort of offering, financing or otherwise fund raise. The confusing part of this whole thing is the lack of money but the absence of something to

Eicosapentaenoic acid (EPA) reduced lipopolysaccharide-stimulated inflammatory response of RAW264.7 cells via the miR-125b-5p/CREB axis
Available online 24 April 2025
https://www.sciencedirect.com/science/article/abs/pii/S0141813025040632

POLICY PRIORITIESNew DOJ Partial to Populist Antitrust

Wrong again, just like with this stock. It's free to look back at all previous posts and copy and paste them. There were numerous examples to choose from, but I thought that was a very good example. As for your accusation about having a subscription under two different posters, also wrong. What I th

POLICY PRIORITIESNew DOJ Partial to Populist Antitrust